Carboplatin intensification shown beneficial for group 3 medulloblastoma
(HealthDay)—For children with high-risk group 3 medulloblastoma, therapy intensification with carboplatin improves event-free survival, according to a study published online July 22 in JAMA Oncology.
Jul 23, 2021
0
1